Janney Montgomery Scott LLC Has $457,000 Holdings in Stevanato Group S.p.A. (NYSE:STVN)

Janney Montgomery Scott LLC cut its holdings in shares of Stevanato Group S.p.A. (NYSE:STVN) by 12.4% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 14,100 shares of the company’s stock after selling 2,000 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Stevanato Group were worth $457,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Bank of New York Mellon Corp lifted its holdings in shares of Stevanato Group by 11.4% during the 1st quarter. Bank of New York Mellon Corp now owns 46,717 shares of the company’s stock valued at $940,000 after buying an additional 4,798 shares during the last quarter. BlackRock Inc. lifted its holdings in Stevanato Group by 3.6% in the 1st quarter. BlackRock Inc. now owns 263,364 shares of the company’s stock worth $5,299,000 after purchasing an additional 9,125 shares during the last quarter. Lazard Asset Management LLC lifted its holdings in Stevanato Group by 3.4% in the 1st quarter. Lazard Asset Management LLC now owns 6,366,679 shares of the company’s stock worth $128,097,000 after purchasing an additional 210,007 shares during the last quarter. UBS Group AG lifted its holdings in Stevanato Group by 79.9% in the 1st quarter. UBS Group AG now owns 1,799 shares of the company’s stock worth $36,000 after purchasing an additional 799 shares during the last quarter. Finally, Wellington Management Group LLP lifted its holdings in Stevanato Group by 21.2% in the 1st quarter. Wellington Management Group LLP now owns 992,326 shares of the company’s stock worth $19,966,000 after purchasing an additional 173,332 shares during the last quarter. 10.90% of the stock is currently owned by institutional investors and hedge funds.

Stevanato Group Trading Down 4.8 %

NYSE STVN opened at €27.35 ($29.10) on Tuesday. The stock has a 50-day simple moving average of €30.96 and a 200 day simple moving average of €30.26. The company has a market capitalization of $8.08 billion, a PE ratio of 47.16, a P/E/G ratio of 4.29 and a beta of 0.85. The company has a current ratio of 1.36, a quick ratio of 0.88 and a debt-to-equity ratio of 0.11. Stevanato Group S.p.A. has a 12 month low of €13.71 ($14.59) and a 12 month high of €36.30 ($38.62).

Stevanato Group (NYSE:STVN) last announced its quarterly earnings results on Friday, July 28th. The company reported €0.15 ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of €0.14 ($0.15) by €0.01 ($0.01). Stevanato Group had a return on equity of 15.12% and a net margin of 14.24%. The company had revenue of €277.92 million during the quarter, compared to the consensus estimate of €275.39 million. Research analysts forecast that Stevanato Group S.p.A. will post 0.63 EPS for the current year.

Wall Street Analyst Weigh In

STVN has been the subject of several analyst reports. Morgan Stanley lowered Stevanato Group from an “overweight” rating to an “equal weight” rating and set a $34.00 target price for the company. in a report on Thursday, August 24th. Wells Fargo & Company boosted their target price on Stevanato Group from $30.00 to $35.00 and gave the stock an “overweight” rating in a report on Monday, July 31st. KeyCorp boosted their target price on Stevanato Group from $35.00 to $37.00 and gave the stock an “overweight” rating in a report on Wednesday, August 30th. Stephens began coverage on Stevanato Group in a research report on Monday, September 25th. They issued an “overweight” rating and a $33.00 price target on the stock. Finally, CJS Securities began coverage on Stevanato Group in a research report on Tuesday, September 19th. They issued an “outperform” rating and a $36.00 price target on the stock. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of €33.63 ($35.77).

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for biopharma and healthcare. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.